Why the study?
Cardiovascular disease is the leading cause of morbidity and mortality in women, yet significant gender inequalities persist in clinical trial representation, public perception, risk factor recognition, and guideline-directed care.
Design
Editorial
Authors
Loading...
Emphasizes equal CVD burden in women despite trial gaps; extends guidelines to address female underrepresentation in evidence.
Key points are not available for this paper at this time.
Lawless et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: